新しいCOVID-19ワクチン戦略は,インフルエンザの年間接種を模倣する
まとめ
科学者や規制当局者は 未定の道を進んでいます これには新たな課題に対処し,将来の進歩を確保するための新しい戦略的アプローチが必要です.
科学分野:
- 環境科学と規制政策
- 分野間の研究とリスク評価
背景:
- 現在の科学的な理解は 重要な不確実性に直面しています
- 既存の規制の枠組みは,新しい課題に適切に対処できないかもしれません.
関連する概念動画
Vaccinations
45.1K
Overview
45.1K
Cross-reactivity
31.4K
Overview
31.4K
Viral Recombination
23.7K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
23.7K
Leaky Scanning
5.2K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.2K
Cancer Vaccines
473
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
473


